J-Lex

Alixtra subcutaneous injection 1.5mg

Alixtra subcutaneous injection 1.5mg, from Sand Pharma, contains Fondaparinux sodium, a selective factor Xa inhibitor used to prevent and treat deep vein thrombosis and pulmonary embolism. It is an injectable drug with a YJ code of 3339400G1029 and a standard of 1.5 mg in 0.3 mL per tube.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer